Table 1 Antifungal susceptibility of Candida albicans from different sources to five common antifungal agents.

From: Virulence factors, biofilm formation and antifungal resistance in Candida albicans from recurrent vulvovaginal candidiasis patients: a comparative study

Antimicrobial agents

MIC

(mg/L)

RVVC patients(n = 50)

Vaginal colonization(n = 50)

Z/χ²-value

P-value

Amphotericin B

Min

0.125

0.06

3.426

0.017

P25

0.5

0.25

P50

0.5

0.5

P75

0.5

0.5

Max

4

1

Sensitivity rate (%)

96

100

-

0.495

5-Fluorocytosine

Min

≤ 0.015

≤ 0.015

3.876

0.007

P25

0.06

0.03

P50

0.25

0.125

P75

0.5

0.25

Max

4

1

Sensitivity rate (%)

100

100

-

1.000

Fluconazole

Min

0.06

0.03

5.241

<0.001

P25

0.25

0.125

P50

1

0.5

P75

4

1

Max

≥ 128

32

Sensitivity rate (%)

88

96

-

0.269

Voriconazole

Min

≤ 0.015

≤ 0.015

2.563

0.049

P25

0.06

0.03

P50

0.125

0.06

P75

0.25

0.125

Max

8

4

Sensitivity rate (%)

74

86

5.705

0.017

Itraconazole

Min

≤ 0.015

≤ 0.015

2.674

0.036

P25

0.03

≤ 0.015

P50

0.125

0.06

P75

0.25

0.125

Max

16

8

Sensitivity rate (%)

72

88

6.801

0.009